ORYZON GENOMICS, S.A. 03/04/2020 07:32 ORYZON GENOMICS, S.A. Other relevant information ORYZON presents preliminary efficacy data of vafidemstat from its two Phase IIa clinical trials in Alzheimer’s, REIMAGINE-AD and ETHERAL Register number: 1373